A Phase 1, Randomized, Placebo‐Controlled Study of Molnupiravir in Healthy Japanese to Support Special Approval in Japan to Treat COVID ‐19
Clinical and Translational Science（2022）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要